---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-25-008694"
form_type: "8-K"
ticker: "PTCT"
cik: "0001070081"
company_name: "PTC THERAPEUTICS, INC."
filed_at: "2025-06-17T23:59:59+00:00"
generated_at: "2026-05-19T04:10:51.568176+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# PTC Therapeutics reports results of 2025 annual meeting; all three proposals approved

## Summary
- Elected Allan Jacobson (60,386,986 for), David Southwell (59,200,375), Alethia Young (54,894,657) as Class III directors to 2028 term.
- Ratified Ernst & Young as independent auditor for FY 2025: 67,259,475 for, 195,233 against, 21,362 abstained.
- Approved non-binding advisory vote on executive compensation: 60,479,157 for, 1,979,310 against, 44,711 abstained.

## SEC filing metadata
- accession: 0001558370-25-008694
- form_type: 8-K
- ticker: PTCT
- cik: 0001070081
- company_name: PTC THERAPEUTICS, INC.
- filed_at: 2025-06-17T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1070081/000155837025008694/0001558370-25-008694-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1070081/000155837025008694/tmb-20250617x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-25-008694
- JSON: https://secwatch.observer/filing/0001558370-25-008694.json
- Plain text: https://secwatch.observer/filing/0001558370-25-008694.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.